Supply Chain | February 10, 2026
Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
HCG clinicians contributing to one of the largest bodies of oncology research from India
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype
Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
Novo Medi Sciences aims to reach millions nationwide and provide NEXIPOX PLUS vaccination against chickenpox to thousands of underprivileged girl children
Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs
Subscribe To Our Newsletter & Stay Updated
